Free tool
Healthcare stocks
We cover 34 companies in the Healthcare sector. The median market value in the group is $264.01B. Across the group, the median move over the past trading day is −0.15%. 85% of the 34 with a 200-day average trade above it. Price change over the past year runs from −11.2% to +74.7% across the middle 80 percent of the group, with a median of +28.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
34 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.12T | Mega cap | +68.40% |
| LLY | Eli Lilly and Company | $1.10T | Mega cap | +78.28% |
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +69.06% |
| JNJ.DE | Johnson & Johnson | $659.04B | Mega cap | +54.31% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +56.92% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +48.73% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +29.69% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +31.10% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +23.44% |
| MRCK34.SA | Merck & Co., Inc. | $384.82B | Mega cap | +77.08% |
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% |
| RHO.DE | Roche Holding AG | $377.17B | Mega cap | +39.70% |
| MRK | Merck & Co., Inc. | $371.70B | Mega cap | +88.17% |
| NOT.DE | NOVARTIS AG N | $303.40B | Mega cap | +27.82% |
| N1VS34.SA | Novartis AG | $303.05B | Mega cap | +20.51% |
| NVS | Novartis AG | $300.35B | Mega cap | +31.84% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +1.98% |
| AZN.ST | AstraZeneca PLC | $263.97B | Mega cap | +2.47% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +7.60% |
| A1ZN34.SA | AstraZeneca PLC | $260.90B | Mega cap | +1.51% |
| AMG.DE | Amgen Inc. | $241.28B | Mega cap | +56.55% |
| AMGN34.SA | Amgen Inc. | $239.24B | Mega cap | +47.86% |
| AMGN | Amgen Inc. | $239.09B | Mega cap | +56.64% |
| TMO | Thermo Fisher Scientific Inc. | $232.26B | Mega cap | +28.46% |
| TN8.DE | Thermo Fisher Scientific Inc. | $231.85B | Mega cap | +27.50% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | $231.50B | Mega cap | +22.09% |
| NVO | Novo Nordisk A/S | $215.18B | Mega cap | −10.46% |
| NOV.DE | Novo Nordisk A/S | $213.87B | Mega cap | +11.69% |
| NOVO-B.CO | Novo Nordisk A/S | $212.57B | Mega cap | −13.21% |
| N1VO34.SA | Novo Nordisk A/S | $210.56B | Mega cap | −17.65% |
| NVO.WA | NVONORDSK | $210.19B | Mega cap | −11.47% |
| ABT | Abbott Laboratories | $202.28B | Mega cap | −10.54% |
| ABTT34.SA | Abbott Laboratories | $201.07B | Mega cap | −15.33% |
| ABL.DE | Abbott Laboratories | $200.83B | Mega cap | −9.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.